Paul R Michl
Examiner (ID: 9867)
Most Active Art Unit | 1505 |
Art Unit(s) | 1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509 |
Total Applications | 2093 |
Issued Applications | 1688 |
Pending Applications | 51 |
Abandoned Applications | 353 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7651835
[patent_doc_number] => 20110301104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Transition state structure of orotate phosphoribosyl transferases and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/998614
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10000
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301104.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998614
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998614 | Transition state structure of orotate phosphoribosyl transferases and uses thereof | Nov 17, 2009 | Abandoned |
Array
(
[id] => 6591668
[patent_doc_number] => 20100130527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'INDIVIDUALIZED CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/621408
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 30779
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130527.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621408
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621408 | Individualized cancer treatment | Nov 17, 2009 | Issued |
Array
(
[id] => 6317222
[patent_doc_number] => 20100112627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'System and Method for Displaying Three-Dimensional Object Scattergrams'
[patent_app_type] => utility
[patent_app_number] => 12/609843
[patent_app_country] => US
[patent_app_date] => 2009-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6660
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12609843
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/609843 | System and Method for Displaying Three-Dimensional Object Scattergrams | Oct 29, 2009 | Abandoned |
Array
(
[id] => 7500339
[patent_doc_number] => 20110262907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'PROCECURE FOR PREPARING A PROCESSED VIRTUAL ANALYSIS IMAGE'
[patent_app_type] => utility
[patent_app_number] => 13/126650
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3035
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262907.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126650
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126650 | PROCECURE FOR PREPARING A PROCESSED VIRTUAL ANALYSIS IMAGE | Oct 27, 2009 | Abandoned |
Array
(
[id] => 6040156
[patent_doc_number] => 20110093205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'PROTEOMICS PREVIEWER'
[patent_app_type] => utility
[patent_app_number] => 12/581503
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7127
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20110093205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581503 | PROTEOMICS PREVIEWER | Oct 18, 2009 | Abandoned |
Array
(
[id] => 6251279
[patent_doc_number] => 20100138205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'STOCHASTIC MOLECULAR BINDING SIMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/578433
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5126
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20100138205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578433 | STOCHASTIC MOLECULAR BINDING SIMULATION | Oct 12, 2009 | Abandoned |
Array
(
[id] => 6256882
[patent_doc_number] => 20100029569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Pharmaceutical Formulation'
[patent_app_type] => utility
[patent_app_number] => 12/575886
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7071
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12575886
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575886 | Pharmaceutical formulation | Oct 7, 2009 | Issued |
Array
(
[id] => 6300144
[patent_doc_number] => 20100161530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'METHOD FOR ENHANCED ACCURACY IN PREDICTING PEPTIDES ELUTION TIME USING LIQUID SEPARATIONS OR CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 12/573738
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8164
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20100161530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573738 | METHOD FOR ENHANCED ACCURACY IN PREDICTING PEPTIDES ELUTION TIME USING LIQUID SEPARATIONS OR CHROMATOGRAPHY | Oct 4, 2009 | Abandoned |
Array
(
[id] => 8314407
[patent_doc_number] => 20120191435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'METHOD OF ACQUIRING PROTEINS WITH HIGH AFFINITY BY COMPUTER AIDED DESIGN'
[patent_app_type] => utility
[patent_app_number] => 13/497859
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9566
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497859
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497859 | METHOD OF ACQUIRING PROTEINS WITH HIGH AFFINITY BY COMPUTER AIDED DESIGN | Sep 24, 2009 | Abandoned |
Array
(
[id] => 6245702
[patent_doc_number] => 20100136023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/558948
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 22440
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136023.pdf
[firstpage_image] =>[orig_patent_app_number] => 12558948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558948 | THERAPEUTIC AGENTS | Sep 13, 2009 | Abandoned |
Array
(
[id] => 16985663
[patent_doc_number] => 11072821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Identifying transition points in chemical reactions
[patent_app_type] => utility
[patent_app_number] => 13/394440
[patent_app_country] => US
[patent_app_date] => 2009-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 7131
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394440
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/394440 | Identifying transition points in chemical reactions | Sep 11, 2009 | Issued |
Array
(
[id] => 6233234
[patent_doc_number] => 20100185419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'ALGORITHM FOR DESIGNING IRREVERSIBLE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/554433
[patent_app_country] => US
[patent_app_date] => 2009-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 33054
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20100185419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12554433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/554433 | ALGORITHM FOR DESIGNING IRREVERSIBLE INHIBITORS | Sep 3, 2009 | Abandoned |
Array
(
[id] => 6376729
[patent_doc_number] => 20100076173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'SYSTEMS AND METHODS FOR GENERATING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/548211
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7962
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076173.pdf
[firstpage_image] =>[orig_patent_app_number] => 12548211
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/548211 | SYSTEMS AND METHODS FOR GENERATING PEPTIDES | Aug 25, 2009 | Abandoned |
Array
(
[id] => 5375481
[patent_doc_number] => 20090313042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Fulfilling Demand for Particular Blood Group Types'
[patent_app_type] => utility
[patent_app_number] => 12/546234
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7859
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20090313042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12546234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/546234 | Fulfilling Demand for Particular Blood Group Types | Aug 23, 2009 | Abandoned |
Array
(
[id] => 8703465
[patent_doc_number] => 08396700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Aggregate simulation'
[patent_app_type] => utility
[patent_app_number] => 12/543205
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8761
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543205
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543205 | Aggregate simulation | Aug 17, 2009 | Issued |
Array
(
[id] => 5304996
[patent_doc_number] => 20090299648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric'
[patent_app_type] => utility
[patent_app_number] => 12/541273
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 13455
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20090299648.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541273
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541273 | Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric | Aug 13, 2009 | Abandoned |
Array
(
[id] => 5304997
[patent_doc_number] => 20090299649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric'
[patent_app_type] => utility
[patent_app_number] => 12/541278
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 13458
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20090299649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541278
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541278 | Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric | Aug 13, 2009 | Abandoned |
Array
(
[id] => 7797938
[patent_doc_number] => 08126654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Identification and monitoring of systemic lupus erythematosus'
[patent_app_type] => utility
[patent_app_number] => 12/538001
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5779
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/126/08126654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12538001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/538001 | Identification and monitoring of systemic lupus erythematosus | Aug 6, 2009 | Issued |
Array
(
[id] => 6631169
[patent_doc_number] => 20100035295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Systems to analyze cellular metabolism and cell and molecular reactions'
[patent_app_type] => utility
[patent_app_number] => 12/462534
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5482
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035295.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462534
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462534 | Systems to analyze cellular metabolism and cell and molecular reactions | Aug 4, 2009 | Abandoned |
Array
(
[id] => 6304236
[patent_doc_number] => 20100068695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Inhibitor for enzyme having two divalent metal ions as active center'
[patent_app_type] => utility
[patent_app_number] => 12/458904
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39211
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12458904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/458904 | Inhibitor for enzyme having two divalent metal ions as active center | Jul 26, 2009 | Abandoned |